Notice of Transition to Company with Audit and Supervisory Committee and New Board of Directors Appointments

October 2,2023
J-Pharma Co., Ltd.

J-Pharma Co., Ltd. (Headquarters: Yokohama, Kanagawa; Masuhiro Yoshitake, President & CEO) resolved at an Extraordinary General Meeting of Shareholders held on September 11, 2023, transition from a company with a board of auditors to a company with an audit and supervisory committee effective October 1, 2023. In addition, we announce that the following appointments of directors were resolved at the Extraordinary General Meeting of Shareholders. Also, the appointment of a representative director was resolved at the subsequent meeting of the Board of Directors dated October 1, 2023.

Transition to Company with Audit and Supervisory Committee

(1) Purpose of the Transition

The Company has decided transition from a company with a Board of Corporate Auditors to a company with an Audit and Supervisory Committee in order to build a structure that can more accurately meet the expectations of stakeholders in Japan and overseas by shifting to a company with an Audit and Supervisory Committee, which will enable the Board of Directors to strengthen its supervisory function and further expedite management decision-making and business execution.

(2) Timing of Transition to Company with Audit and Supervisory Committee

The Company transitioned to a Company with Audit and Supervisory Committee as of October 1, 2023.

2. Directors after the Transition to Company with Audit and Supervisory Committee

(1) Directors (excluding those who are members of the Audit and Supervisory Committee)

Name	New Title/Function	Current Title/Function
Masuhiro Yoshitake	Representative Director, President and CEO	Representative Director President and CEO
Yutaka Fujimoto	Director and Chief Financial Officer	Director and Chief Financial Officer
Sadashi Suzuki	External Director	External Director
Shinichiro Komoto	External Director	External Director
Kazunobu Nishimura	External Director	External Director

(2) Directors who are Audit and Supervisory Committee Members

Name	New Title/Function	Current Title/Function
Toshiyuki Mori	External Director, Audit and Supervisory Committee Member	External Director
Teruhisa Tajima	External Director, Audit and Supervisory Committee Member	External Corporate Auditor
Kosaku Kawaguchi	External Director, Audit and Supervisory Committee Member	External Corporate Auditor

(3) Retiring Corporate Auditor

Name	Current Position
Tadashi Takeuchi	Corporate Auditor

For inquiries regarding this matter, please contact:

J-Pharma Corporation
Public Relations, Administration Department
J-Pharma Co., Ltd.
Fax: 045-506-1156
info@j-pharma.com